Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis

Oncogenic KRAS is the key driver of pancreatic ductal adenocarcinoma (PDAC). We previously described a role for KRAS in PDAC tumor maintenance through rewiring of cellular metabolism to support proliferation. Understanding the details of this metabolic reprogramming in human PDAC may provide novel t...

Descripción completa

Detalles Bibliográficos
Autores principales: Santana-Codina, Naiara, Roeth, Anjali A., Zhang, Yi, Yang, Annan, Mashadova, Oksana, Asara, John M., Wang, Xiaoxu, Bronson, Roderick T., Lyssiotis, Costas A., Ying, Haoqiang, Kimmelman, Alec C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251888/
https://www.ncbi.nlm.nih.gov/pubmed/30470748
http://dx.doi.org/10.1038/s41467-018-07472-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251888/
https://www.ncbi.nlm.nih.gov/pubmed/30470748
http://dx.doi.org/10.1038/s41467-018-07472-8

Ejemplares similares